Cytokinetics | CYTK - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Amgen USD 657M 4M 2026-03
Arca Biopharma USD 504K 246K 2024-09
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
Bristol-Myers Squibb USD 411M 21M 2026-03
Capricor Therapeutics 3.05M 2.46M 2025-12
Cytokinetics USD 33.34M 3M 2026-03
Eisai JPY 1.55B 117M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Exelixis USD 23.4M 3.9M 2023-09
Geron USD 7.15M 150K 2026-03
Halozyme Therapeutics USD 5.51M 597K 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
Merck USD 479M 67M 2026-03
Novartis USD 343M 39M 2026-03
Pfizer USD 671M 40M 2026-03
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sanofi EUR 178M 203M 2026-03